Initiating insulin in type 2 diabetes

被引：0

作者：

Dailey, George ^{[1
]}

机构：

[1] Scripps Clin, Div Diabet & Endocrinol, La Jolla, CA 92037 USA

来源：

DRUG DEVELOPMENT RESEARCH | 2008年 / 69卷 / 03期

关键词：

insulin; T2DM; banal insulin; prandial insulin;

D O I：

10.1002/ddr.20235

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

There are a variety of oral hypoglycemic agents available for use in type 2 diabetes. Despite the increasing choices of oral agents, insulin therapy remains the most effective means to lower blood glucose and often must be used. There is some controversy as to the best approach to the initiation of insulin treatment in type 2 diabetes. The approach we favor begins with basal insulin with later addition of premeal rapid-acting insulin.

引用

页码：116 / 118

页数：3

共 50 条

[41] Efficacy and Safety of Continuing Sitagliptin when Initiating Insulin Therapy in Subjects with Type 2 Diabetes Mellitus
Roussel, Ronan
Duran-Garcia, Santiago
Zhang, Yilong
Shah, Suneri
Darmiento, Carolyn
Shankar, R. Ravi
O'Neill, Edward A.
Golm, Gregory T.
Lam, Raymond L.
Gantz, Ira
Kaufman, Keith D.
Engel, Samuel S.
DIABETES, 2018, 67
[42] Economic evaluation of initiating insulin detemir among type 2 diabetes patients receiving oral medication
Palmer, A. J.
Cobden, D.
Valentine, W. J.
Wagner, S.
Roze, S.
VALUE IN HEALTH, 2006, 9 (06) : A230 - A230
[43] Treatment Patterns and Characteristics of Individuals Initiating High-Dose Insulin for Type 2 Diabetes Mellitus
Chen, Jieling
Nair, Radhika
Siadaty, Mir
Brown, Katelyn
Meah, Yunus
Taylor, April Dawn
He, Xuanyao
Fan, Ludi
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (07): : 839 - +
[44] Patients with type 2 diabetes initiating exenatide twice daily or insulin in clinical practice: CHOICE study
Matthaei S.
Reaney M.
Mathieu C.
Östenson C.-G.
Krarup T.
Guerci B.
Kiljanski J.
Petto H.
Bruhn D.
Theodorakis M.
Diabetes Therapy, 2012, 3 (1) : 1 - 15
[45] Recommendations for Initiating Use of Afrezza Inhaled Insulin in Individuals with Type 1 Diabetes
Pettus, Jeremy
Santos Cavaiola, Tricia
Edelman, Steven V.
DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (06) : 448 - 451
[46] Effect of Adherence and Insulin Delivery System on Clinical and Economic Outcomes among Patients with Type 2 Diabetes Initiating Insulin Treatment
Ayyagari, Rajeev
Wei, Wenhui
Cheng, David
Pan, Chunshen
Signorovitch, James
Wu, Eric Q.
VALUE IN HEALTH, 2015, 18 (02) : 198 - 205
[47] COST-EFFECTIVENESS OF INSULIN DEGLUDEC COMPARED WITH INSULIN GLARGINE FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATING INSULIN THERAPY IN THE UNITED KINGDOM
Evans, M.
Chubb, B.
Christensen, T.
Gundgaard, J.
Wolden, M.
VALUE IN HEALTH, 2013, 16 (07) : A442 - A442
[48] Time to insulin initiation and long-term effects of initiating insulin in people with type 2 diabetes mellitus: the Hoorn Diabetes Care System Cohort Study
Mast, Ruth
Jansen, A. P. Danielle
Walraven, Iris
Rauh, Simone P.
van der Heijden, Amber A. W. A.
Heine, Robert J.
Elders, Petra J. M.
Dekker, Jacqueline M.
Nijpels, Giel
Hugtenburg, Jacqueline G.
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 174 (05) : 563 - 571
[49] Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study
Jones, Stephen
Benroubi, Marian
Castell, Conxa
Goday, Albert
Liebl, Andreas
Timlin, Louise
Nicolay, Claudia
Simpson, Alexander
Tynan, Aodan
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) : 691 - 700
[50] Identifying Barriers to Initiating Insulin Therapy in Uncontrolled Type 2 Diabetes Patients in a Medical Resident Ambulatory Clinic
Han, Boram
Fasolo, Lucas R.
Malone, Mariuxi V.
Lock, John P.
DIABETES, 2017, 66 : A216 - A216

← 1 2 3 4 5 →